Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
35 results
  1. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... GD, et al.: Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. ...
  2. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    ... taxane agent (e.g., paclitaxel, docetaxel) or liposomal doxorubicin.7-9 For recurrence, several chemotherapy regimens (e.g., docetaxel, paclitaxel, gemcitabine, liposomal doxorubicin, topotecan and etoposide) may be ...
  3. NLM Digital Collections - Management of epithelial ovarian cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), 2013
    resource.nlm.nih.gov/101671098
    ... cancer what is the optimal chemotherapy 6.3 regimen? Consider: platinum (carboplatin), taxanes (paclitaxel), topotecan, bevacizumab, gemcitabine, trabectedin, pegylated liposomal doxorubicin; consider mono and combination therapies (eg single agent ...
  4. Carcinoma of Unknown Primary Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65811
    ... bleomycin, and cisplatin; however, some patients received a doxorubicin-containing ... A paclitaxel-based combination yielded a 48% response rate in ...
  5. NLM Digital Collections - Indication-specific pricing of pharmaceuticals in the United States health care system : a ... 
    Publication: Boston, MA : Institute for Clinical and Economic Review, March 2016
    resource.nlm.nih.gov/101704608
    ... EC in July 2014, was: in combination with paclitaxel, topotecan, or ... prior chemotherapy regimens and who have not received prior therapy with ...
  6. Systemic Therapy - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82144
    ... The studies investigated a variety of combination chemotherapy regimens ... taxanes (paclitaxel and docetaxel) and from 2003 onwards trials investigated ...
  7. Appendices - Early and locally advanced breast cancer: diagnosis and management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK541684
    ... as less than 60% agreement 7 Taxane-containing regimens may reduce cardiac ... with doxorubicin 0 Discarded as less than 60% agreement 10 ...
  8. NLM Digital Collections - Treatment of primary breast cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), September 2013
    resource.nlm.nih.gov/101671096
    ... A, et al. Feasibility and tolerability of sequential doxorubicin/ paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its ...
  9. Articles Excluded at Full-Text Screening by Reason - Progression-Free Survival: What Does It Mean for Psychological ... 
    https://www.ncbi.nlm.nih.gov/books/NBK137765
    ... PubMed : 22234633 ] Refid: 1628. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results ...
  10. Urethral Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65918
    ... contains the following:[ 1 , 4 - 7 ] Methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC). Paclitaxel. Carboplatin. Ifosfamide, with occasional complete responses. Chemotherapy has ...
first · previous · 1 · 2 · 3 · 4 · next · last